Slow Tech and ICT Authors:
Satisfies the need for a more proactive computer ethics that addresses issues at design stage
Lays out a set of ethical principles that can be applied to real-life business settingssee more benefits
Buy this book
Immediate eBook download after purchase Hardcover $54.99
Institutional customers should get in touch with their account manager Softcover $54.99
Institutional customers should get in touch with their account manager
This book makes an important contribution to the recent evolution in Information and Communication Technologies (ICT) that are human-centred and socially desirable, environmentally sustainable, and ethically acceptable. It introduces the concept of moral, equitable and environmental limits in the ICT domain and proposes a Slow Tech approach to face the challenges of these limits, laying out a set of principles that can be applied in real-
Posted on 7440
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures.
Dr. Samuel Cohen, Chief Executive Officer of Wren, commented: “This support from both our existing as well as our new shareholders will accelerate the advancement of our two lead small molecule programs towards the clinic for the potential treatment of Alzheimer’s disease and various synucleinopathies including Parkinson’s disease.”
Press release content from Business Wire. The AP news staff was not involved in its creation.
Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)
January 25, 2021 GMT
CAMBRIDGE, United Kingdom (BUSINESS WIRE) Jan 25, 2021
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.
This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures.
India International Science Festival 2020 Witnesses Innovative Interventions to Contribute Towards the Building of a Self-reliant India
India International Science Festival 2020 witnesses innovative interventions to contribute towards the building of a self-reliant India ANI | Updated: Dec 23, 2020 13:50 IST
The objective of the event was to provide a platform to participants to contribute towards nation-building by coming up with novel solutions to societal problems, that would, in turn, result in reciprocation of knowledge and emergence of ideas for the national interest. The identified Plenary Sessions Igniting Young Minds for Solution centric STI Interventions .
The India International Science Festival (IISF) will provide the spark of innovativeness and a strong belief in science and scientists among the country s citizens that will catapult the country into becoming a world leader.
IISF 2020 witnesses innovative interventions indiagazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiagazette.com Daily Mail and Mail on Sunday newspapers.